MedTrace Logo

Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation

NCT01282606 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-03-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of SI-6603 in lumbar disc herniation patients.

Conditions

  • Lumbar Vertebra Hernia

Interventions

DRUG

SI-6603

SI-6603 is administrated into the nucleus pulposus of an intervertebral disc.

Sponsors & Collaborators

  • Seikagaku Corporation

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282606 on ClinicalTrials.gov